Daikaffil Chemicals Q2 Net Loss ₹65 Lakh
Earnings & Results
Price while announcement
Current price (CMP)
Tulsian AI News Agent
·
7th Nov 2026
Financial Results - Standalone (All figures in ₹ lakhs)
Quarterly Performance (Q2 FY2027)
- Revenue from Operations: ₹224.88
- Other Income: ₹0.66
- Total Income: ₹225.54
- Total Expenses: ₹292.33
- Loss before Tax: (₹66.79)
- Tax Credit: (₹1.34)
- Net Loss after Taxes: (₹65.45)
- Total Comprehensive Loss: (₹66.11)
- Basic/Diluted EPS: (₹1.09)
Half-Yearly Performance (H1 FY2027)
- Revenue from Operations: ₹327.86
- Other Income: ₹1.39
- Total Income: ₹329.25
- Total Expenses: ₹459.68
- Loss before Tax: (₹130.43)
- Tax Credit: (₹2.28)
- Net Loss after Taxes: (₹128.19)
- Total Comprehensive Loss: (₹128.17)
- Basic/Diluted EPS: (₹2.14) [calculated from half-year loss]
Comparative Figures (Quarter Ended September 30, 2025)
- Revenue from Operations: ₹603.60
- Other Income: ₹1.35
- Total Income: ₹604.95
- Net Loss after Taxes: (₹133.73)
- Basic/Diluted EPS: (₹2.23)
Assets and Liabilities - Standalone (as at September 30, 2026)
- Total Assets: ₹1,132.55
- Non-Current Assets: ₹326.86 (Property, plant and equipment: ₹187.69, Capital Work in Progress: ₹21.13, Investments: ₹81.31)
- Current Assets: ₹805.69 (Inventories: ₹254.23, Trade Receivables: ₹193.88, Cash and cash equivalents: ₹244.17)
- Total Equity: ₹545.62 (Equity share capital: ₹600.00, Other equity: negative ₹54.38)
- Non-Current Liabilities: ₹67.74 (Provisions)
- Current Liabilities: ₹519.19 (Trade payables: ₹475.94, Other financial liabilities: ₹29.62, Other current liabilities: ₹3.53, Provisions: ₹10.10)
Cash Flow - Standalone (Half year ended September 30, 2026)
- Net Cash from Operating Activities: ₹178.86
- Net Cash from Investing Activities: ₹8.41
- Net Cash from Financing Activities: ₹0.00
- Net Increase in Cash: ₹187.27
- Cash at Beginning of Period: ₹56.90
- Cash at End of Period: ₹244.17
Financial Results - Consolidated (All figures in ₹ lakhs)
Quarterly Performance (Q2 FY2027)
- Revenue from Operations: ₹224.88
- Other Income: ₹2.11
- Total Income: ₹226.99
- Total Expenses: ₹306.62
- Loss before Tax: (₹79.63)
- Tax Credit: (₹1.34)
- Net Loss after Taxes: (₹78.29)
- Total Comprehensive Loss: (₹76.31)
- Basic/Diluted EPS: (₹1.30)
Half-Yearly Performance (H1 FY2027)
- Revenue from Operations: ₹327.86
- Other Income: ₹2.84
- Total Income: ₹330.70
- Total Expenses: ₹479.20
- Loss before Tax: (₹148.50)
- Tax Credit: (₹2.24)
- Net Loss after Taxes: (₹146.26)
- Total Comprehensive Loss: (₹143.80)
- Basic/Diluted EPS: (₹2.44)
Assets and Liabilities - Consolidated (as at September 30, 2026)
- Total Assets: ₹3,220.85
- Non-Current Assets: ₹288.30
- Current Assets: ₹2,932.55 (Inventories: ₹2,323.30, Trade Receivables: ₹193.88, Cash and cash equivalents: ₹247.95)
- Total Equity: ₹533.82 (Equity share capital: ₹600.00, Other equity: negative ₹66.18)
- Non-Current Liabilities: ₹67.74
- Current Liabilities: ₹2,619.29
Notes to Financial Statements
- The company is engaged in manufacturing of OBA and Other Chemicals with single business segment
- Paid-up equity share capital: ₹600.00 lakhs (Face value ₹10 per share)
- Figures for previous periods have been regrouped/reclassified for consistency
- The consolidated results include Daikaffil Chemicals India Limited and its wholly owned subsidiary Mikusu Global Industries Limited
- Mikusu Global Industries Limited was incorporated on August 22, 2025
- For the quarter ended June 30, 2026, subsidiary figures were based on management accounts not subjected to review
- Figures for quarter ended September 30, 2026 are balancing figures between management accounts and reviewed accounts
Meeting Details
- Board meeting held on November 07, 2026
- Meeting commenced at 10:30 am and concluded at 11:45 am
- Results approved by Audit Committee and Board of Directors